Gene · 9113
Papers3,081
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
61 to 80 of 3,081
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| CCT5 as a candidate biomarker in bladder cancer: functional validation and mechanistic clues. | Am J Cancer Res | 2026 | 41657783 | PubTator, text mining | PubMed |
| Targeting the PTCHD1-hippo axis by rhPTH(1-34) restores contact inhibition and suppresses hyperproliferation in psoriatic keratinocytes. | Eur J Pharmacol | 2026 | 41651334 | PubTator, text mining | PubMed |
| HCV infection induces ubiquitin-dependent degradation of LATS1, inactivating the Hippo pathway and upregulating transcription of the CYR61 and CTGF genes. | J Gen Virol | 2026 | 41642640 | PubTator, text mining | PubMed |
| Tapentadol induces progressive hepatic damage via disrupting Hippo-YAP and bile acid-FXR pathways: An integrated experimental and computational perspective. | Tissue Cell | 2026 | 41637922 | PubTator, text mining | PubMed |
| [Quercetin inhibits proliferation and migration and promotes apoptosis of gastric cancer cells by promoting phosphorylation-mediated YAP inactivation]. | Nan Fang Yi Ke Da Xue Xue Bao | 2026 | 41633694 | PubTator, text mining | PubMed |
| Regulation of tension-dependent localization of LATS1 and LATS2 to adherens junctions. | PLoS One | 2026 | 41628219 | PubTator, text mining | PubMed |
| High-throughput single-cell DNA methylation and chromatin accessibility co-profiling with SpliCOOL-seq. | Clin Transl Med | 2026 | 41603298 | PubTator, text mining | PubMed |
| Dose-dependent activation of the Hippo pathway by Type I and Type III interferons suppresses tissue repair by human bronchial epithelial cells. | PLoS Biol | 2026 | 41587178 | PubTator, text mining | PubMed |
| Crystal structure of the cell-cycle regulatory monopolar spindle one binder (LdMOB1) protein: Identification of potential distinct phosphorylation sites. | Int J Biol Macromol | 2026 | 41577278 | PubTator, text mining | PubMed |
| Integrative multi-omics and machine learning framework identifies PRDX4 as a redox-EMT regulator and predictive marker in bone-metastatic breast cancer. | NPJ Precis Oncol | 2026 | 41571856 | PubTator, text mining | PubMed |
| A kinase inhibitor screen identifies GSK690693 as a Hippo pathway inhibitor targeting ER-positive breast cancer. | J Biochem | 2026 | 41527804 | PubTator, text mining | PubMed |
| Fertility under fire: how chemotherapy harms the ovaries and the science fighting back? | J Ovarian Res | 2026 | 41501826 | PubTator, text mining | PubMed |
| Dynamic and selective competition governs binding of large tumor suppressor 1 to KIBRA and YAP. | Protein Sci | 2026 | 41427739 | PubTator, text mining | PubMed |
| Germline lung cancer SNPs dysregulate known (LATS1) and novel (ADCY2) oncogenes through distal, spatially-constrained eQTLs. | Cancer Genet | 2026 | 41317429 | PubTator, text mining | PubMed |
| GPSAdb 2.0: an expanded atlas of gene-perturbation transcriptomes with enhanced tools for regulatory gene discovery. | Nucleic Acids Res | 2026 | 41160887 | PubTator, text mining | PubMed |
| FGF2-regulated Osteogenic Differentiation of Human Bone Marrow Stromal Cells. | Curr Stem Cell Res Ther | 2026 | 40734441 | PubTator, text mining | PubMed |
| Role of FGF2 in promoting osteogenic differentiation for craniofacial bone regeneration. | Regen Eng Transl Med | 2025 | 41583576 | PubTator, text mining | PubMed |
| Expression of Core Hippo Pathway Proteins in Cervical Cancer and Their Association with Clinicopathologic Parameters. | Medicina (Kaunas) | 2025 | 41470136 | PubTator, text mining | PubMed |
| Investigation of the possible effects of LncRNA CYTOR on the molecular mechanisms of metastasis and Hippo signaling pathways in Triple-negative and Cisplatin-resistant breast cancer cell lines. | Med Oncol | 2025 | 41455878 | PubTator, text mining | PubMed |
| Novel variants associated with premature ovarian insufficiency in Russian adolescents. | Front Endocrinol (Lausanne) | 2025 | 41393291 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/9113/papers?page=4